Literature DB >> 6685510

Comparison of the metabolism of oltipraz in the mouse, rat and monkey and in man. Distribution of the metabolites in each species.

A Bieder, B Decouvelaere, C Gaillard, H Depaire, D Heusse, C Ledoux, M Lemar, J P Le Roy, L Raynaud, C Snozzi.   

Abstract

4-Methyl-5-(2-pyrazinyl)-1,2-dithiole-3-thione (35 972 R.P., oltipraz) and its metabolites were extracted from human urine and from mouse, rat and monkey urine using Amberlite XAD4 resin. The metabolites were identified by GLC, TLC and HPLC and isolated by preparative TLC or HPLC. The structures of 11 compounds were determined by spectroscopic examination (MS, IR, NMR). Six of the principal metabolites isolated in sufficient quantity from human urine were administered to the mouse, confirming the metabolic pathways of oltipraz.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6685510

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN: 0004-4172


  8 in total

Review 1.  Multiple peaking phenomena in pharmacokinetic disposition.

Authors:  Neal M Davies; Jody K Takemoto; Dion R Brocks; Jaime A Yáñez
Journal:  Clin Pharmacokinet       Date:  2010-06       Impact factor: 6.447

2.  Synthesis, biological evaluation, and structure-activity relationships of dithiolethiones as inducers of cytoprotective phase 2 enzymes.

Authors:  Rex Munday; Yuesheng Zhang; Joseph D Paonessa; Christine M Munday; Alistair L Wilkins; Jacob Babu
Journal:  J Med Chem       Date:  2010-06-24       Impact factor: 7.446

3.  Interactions of the major metabolite of the cancer chemopreventive drug oltipraz with cytochrome c: a novel pathway for cancer chemoprevention.

Authors:  Murugesan Velayutham; Rajendra B Muthukumaran; Joe Z Sostaric; John McCraken; James C Fishbein; Jay L Zweier
Journal:  Free Radic Biol Med       Date:  2007-07-06       Impact factor: 7.376

4.  Oltipraz, an inhibitor of human immunodeficiency virus type 1 replication.

Authors:  H J Prochaska; Y Yeh; P Baron; B Polsky
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

5.  Pharmacokinetics of oltipraz in diabetic rats with liver cirrhosis.

Authors:  C Y Ahn; S K Bae; S H Bae; T Kim; Y S Jung; Y C Kim; M G Lee; W G Shin
Journal:  Br J Pharmacol       Date:  2009-03       Impact factor: 8.739

6.  Clinical pharmacology studies of oltipraz--a potential chemopreventive agent.

Authors:  N V Dimitrov; J L Bennett; J McMillan; M Perloff; C M Leece; W Malone
Journal:  Invest New Drugs       Date:  1992-11       Impact factor: 3.850

Review 7.  Dithiolethiones for cancer chemoprevention: where do we stand?

Authors:  Yuesheng Zhang; Rex Munday
Journal:  Mol Cancer Ther       Date:  2008-11       Impact factor: 6.261

8.  Anticancer activity and chemoprevention of xenobiotic organosulfurs in preclinical model systems.

Authors:  Robert E Click
Journal:  Oncol Discov       Date:  2013
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.